Skip to Main Content

Author Details

Fredika M Robertson
University of Texas M.D. Anderson Cancer Center
1987
88
34
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35042871Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC.NPJ Breast Cancer2022
24299959Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival.Ann Oncol2014
25495984Targeting SH2 domains in breast cancer.Future Med Chem2014
24852501Potent inhibition by ropivacaine of metastatic colon cancer SW620 cell invasion and NaV1.5 channel function.Br J Anaesth2014
22580607The genesis and unique properties of the lymphovascular tumor embolus are because of calpain-regulated proteolysis of E-cadherin.Oncogene2013
24416998The class I HDAC inhibitor Romidepsin targets inflammatory breast cancer tumor emboli and synergizes with paclitaxel to inhibit metastasis.J Exp Ther Oncol2013
24102046Presence of anaplastic lymphoma kinase in inflammatory breast cancer.Springerplus2013
23647160Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer.J Proteome Res2013
23784380Inflammatory breast cancer (IBC): clues for targeted therapies.Breast Cancer Res Treat2013
23396049Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets.Clin Cancer Res2013
23530113The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism.Oncotarget2013
22638108Early to intermediate steps of tumor embolic formation involve specific proteolytic processing of E-cadherin regulated by Rab7.Mol Cancer Res2012
24058783The consequences of selective inhibition of signal transducer and activator of transcription 3 (STAT3) tyrosine705 phosphorylation by phosphopeptide mimetic prodrugs targeting the Src homology 2 (SH2) domain.JAKSTAT2012
23350355A phosphopeptide mimetic prodrug targeting the SH2 domain of Stat3 inhibits tumor growth and angiogenesis.J Exp Ther Oncol2012
22547109Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.Breast Cancer Res Treat2012
20603440International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.Ann Oncol2011
21903394Efficient synthesis of apricoxib, CS-706, a selective cyclooxygenase-2 inhibitor, and evaluation of inhibition of prostaglandin E2 production in inflammatory breast cancer cells.Bioorg Med Chem Lett2011
21153052Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer.Breast Cancer Res Treat2011
21174535A global approach to inflammatory breast cancer.Future Oncol2011
20159363Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditions.Int J Radiat Oncol Biol Phys2010
20503412Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4.Cancer2010
20503408Suberoylanilide hydroxamic acid blocks self-renewal and homotypic aggregation of inflammatory breast cancer spheroids.Cancer2010
20615238Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells.Mol Cancer2010
20639504Imaging and analysis of 3D tumor spheroids enriched for a cancer stem cell phenotype.J Biomol Screen2010
20643181Toxicological and pathophysiological roles of reactive oxygen and nitrogen species.Toxicology2010
20191427High-Content Analysis--CHI's Seventh Annual Conference--Developments in HCA and Pathway Analysis.IDrugs2010
18663578Nanotechnology for breast cancer therapy.Biomed Microdevices2009
19656995Nitrative and oxidative stress in toxicology and disease.Toxicol Sci2009
19170514Application of physicochemically modified silicon substrates as reverse-phase protein microarrays.J Proteome Res2009
18654487Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications.Nat Nanotechnol2008
19227010Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.J Exp Ther Oncol2008
17465194Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts.Anticancer Res2007
17826110Biomedical nanotechnology for cancer.Med Clin North Am2007
16886599Activation of Akt and mTOR in CD34+/K15+ keratinocyte stem cells and skin tumors during multi-stage mouse skin carcinogenesis.Anticancer Res2006
16997132Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.Prostaglandins Other Lipid Mediat2006
14656937Implications for oxidative and nitrative stress in the pathogenesis of AIDS-related Kaposi's sarcoma.Carcinogenesis2004
15523889Vascular endothelial growth factor as a survival factor in tumor-associated angiogenesis.In Vivo2004
15290792Invasive and angiogenic phenotype of MCF-7 human breast tumor cells expressing human cyclooxygenase-2.Prostaglandins Other Lipid Mediat2004
15517884Activated Akt-1 in specific cell populations during multi-stage skin carcinogenesis.Anticancer Res2004
12820385Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells.Anticancer Res2003
12682914AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.J Cell Biochem2003
12713808The expression of Exonuclease III from E. coli in mitochondria of breast cancer cells diminishes mitochondrial DNA repair capacity and cell survival after oxidative stress.DNA Repair (Amst)2003
12664569Inhibition of ultraviolet light B-induced cutaneous inflammation by a specific cyclooxygenase-2 inhibitor.Adv Exp Med Biol2002
11170110Novel rapid method for visualization of extent and location of aerosol contamination during high-speed sorting of potentially biohazardous samples.Cytometry2001
11272733Inhibition of cutaneous UV light-induced tumor necrosis factor-alpha protein production by Allotrap 1258, a novel immunomodulatory peptide.Photochem Photobiol2001
11730362Protection of human keratinocyte mtDNA by low-level nitric oxide.Nitric Oxide2001
11170241Mechanisms of nitric oxide-induced cytotoxicity in normal human hepatocytes.Environ Mol Mutagen2001
10697514Comparative ability of ibuprofen and N-(4-hydroxyphenyl)retinamide to inhibit development of rat mammary adenocarcinomas associated with differential inhibition of gene expression of cyclooxygenase isoforms.Anticancer Res1999
10403538Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens.Cancer Lett1999
10465664Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer.Med Hypotheses1999
  • 1 - 50 of 88

Recommended Authors

Danh Tran-Thanh
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2002
Number of shared co-authors 0
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Mai Nguyen
University of California Riverside
Career Start Year 1992
Number of shared co-authors 0
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Rosalba Salcedo
Center for Cancer Research, National Cancer Institute
Career Start Year 1990
Number of shared co-authors 0
Susan E Crawford
NorthShore University HealthSystem, Research Institute, 1001 University Place
Career Start Year 1990
Number of shared co-authors 0
Roger Chammas
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 0
Mohammad Athar
University of Alabama at Birmingham
Career Start Year 1987
Number of shared co-authors 0
Steven M Dubinett
David Geffen School of Medicine at university of california los angeles
Career Start Year 1987
Number of shared co-authors 0
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
David J McConkey
Johns Hopkins School of Medicine
Career Start Year 1986
Number of shared co-authors 3
Dean A Troyer
Eastern Virginia Medical School
Career Start Year 1985
Number of shared co-authors 0
Ossama Tawfik
University of Kansas
Career Start Year 1985
Number of shared co-authors 0
Alfredo A Molinolo
University of California
Career Start Year 1984
Number of shared co-authors 2
Adrian L Harris
University of Oxford
Career Start Year 1981
Number of shared co-authors 2
Simon C Watkins
Center for Molecular Imaging, University of Pittsburgh School of Medicine
Career Start Year 1981
Number of shared co-authors 2
Molly Kulesz-Martin
Oregon Health & Science University
Career Start Year 1980
Number of shared co-authors 0
Fabien Calvo
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 0
Craig A Elmets
University of Alabama
Career Start Year 1979
Number of shared co-authors 0
Rakesh K Jain
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1978
Number of shared co-authors 0
Glenn Merlino
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1978
Number of shared co-authors 0
Evelyn Flynn
Boston Children's Hospital
Career Start Year 1978
Number of shared co-authors 0
Christopher C Benz
Buck Institute for Research on Aging
Career Start Year 1977
Number of shared co-authors 1
Donald L Kreutzer
School of Medicine. University of Connecticut
Career Start Year 1977
Number of shared co-authors 0
David W Hedley
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1975
Number of shared co-authors 0
Menashe Bar-Eli
The University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 0
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 0
Erika Ginsburg
National Cancer Institute, National Institutes of Health
Career Start Year 1973
Number of shared co-authors 0
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Career Start Year 1967
Number of shared co-authors 1

Collaborators

Massimo Cristofanilli
Weill Cornell School of Medicine
Co-authored papers 18
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Co-authored papers 7
James M Reuben
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Carol L Sabourin
Battelle Memorial Institute
Co-authored papers 5
Luc Dirix
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Co-authored papers 4
Daniel Birnbaum
Co-authored papers 3
Thomas A Buchholz
Co-authored papers 3
Zhaomei Mu
Thomas Jefferson University Hospital
Co-authored papers 3
William F Symmans
Co-authored papers 2
Emanuel F Petricoin
Center for Applied Proteomics and Molecular Medicine, George Mason University
Co-authored papers 2
William S Hancock
Northeastern University
Co-authored papers 1
Young-Ki Paik
College of Life Sciences and Biotechnology, Yonsei University
Co-authored papers 1
Hogune Im
Genome Opinion Inc.
Co-authored papers 1
Seul-Ki Jeong
Seul-Ki Jeong Neurology Clinic
Co-authored papers 1
Lajos Pusztai
Co-authored papers 1
Ronald C Beavis
University of Manitoba
Co-authored papers 1
Emma Yue Zhang
Co-authored papers 1
Kenneth L van Golen
Co-authored papers 1
Ronald E Cannon
National Institute of Environmental Health Sciences
Co-authored papers 1
Lance A Liotta
Co-authored papers 1
Michael T Lewis
Baylor College of Medicine
Co-authored papers 1
Fan Zhang
Dongzhimen Hospital, Beijing University of Chinese Medicine
Co-authored papers 1
Michael Snyder
Stanford University
Co-authored papers 1
Susan Fanayan
Macquarie University
Co-authored papers 1
Trey Ideker (CM4AI)
University of California San Diego
Co-authored papers 1
Shiaw-Lin Wu
BioAnalytix Inc.
Co-authored papers 1
Gabriel N Hortobagyi
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Gilbert S Omenn
and School of Public Health, University of Michigan ann arbor
Co-authored papers 1
Yuan Qi
Co-authored papers 1
Matan Hofree
Broad Institute of Harvard and MIT
Co-authored papers 1
Release 1.2